Exosens secures €140 million in EIB financing to foster innovation in Europe’s defense and security industry

Exosens has secured €140 million in financing from the European Investment Bank (EIB) backed by the InvestEU programme to support research, development, and innovation in advanced night vision and imaging technologies for European defense and surveillance markets. The facility, with a maturity of up to seven years, will strengthen the company's technological capabilities and position as an ITAR-free supplier of critical photonics solutions.